Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Catherine R LeskoMichael J Mugavero

Abstract

Ensuring equal access to antiretroviral therapy (henceforth therapy) should alleviate disparities in health outcomes among persons infected with human immunodeficiency virus (HIV). However, evidence supporting the persistence of disparities in survival following therapy initiation is mixed. Patients initiating therapy in eight academic medical centers in the Centers for AIDS Research Network of Integrated Clinical Systems between 1 January 1998 and 30 December 2011. Patients (n = 10 017) were followed from therapy initiation until death from any cause, administrative censoring at 10 years after therapy initiation or the end of follow-up on 31 December 2011. The 10-year risk of all-cause mortality was calculated from standardized Kaplan-Meier survival curves. Patients were followed for a median of 4.7 years (interquartile range: 2.2, 8.2). During 51 121 person-years of follow-up, 1224 of the 10 017 patients died. The overall 10-year mortality risk was 20.2% (95% confidence interval [CI], 19.2%, 21.3%). Black men and women experienced standardized 10-year all-cause mortality risks that were 7.2% (95% CI, 4.3%, 10.1%) and 7.9% (95% CI, 3.9%, 12.0%) larger (absolute difference) than white men. White women, Hispanic men, and Hispani...Continue Reading

References

May 26, 2004·Computer Methods and Programs in Biomedicine·Stephen R Cole, Miguel A Hernán
Dec 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kelly A GeboUNKNOWN HIV Research Network
Oct 28, 2005·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Kyriakos S Markides, Karl Eschbach
Feb 12, 2008·International Journal of Epidemiology·Mari M KitahataMichael S Saag
Feb 18, 2009·The Journal of Infectious Diseases·Diana C LemlyStephen P Raffanti
Mar 20, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael J MugaveroMichael S Saag
Jul 18, 2009·Journal of General Internal Medicine·Michael J SilverbergMichael A Horberg
Sep 5, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kathleen McDavid HarrisonXinjian Zhang
Sep 23, 2009·AIDS·UNKNOWN HIV-CAUSAL CollaborationMiguel A Hernán
Jan 20, 2011·The Journal of Infectious Diseases·Amie L MeditzElizabeth Connick
Oct 5, 2011·Epidemiology·Chanelle J HoweJoseph J Eron
Jan 24, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·H Irene HallJonathan Mermin
Mar 3, 2012·AIDS·Baligh R YehiaUNKNOWN HIV Research Network
Sep 25, 2012·HIV Medicine·R WeberUNKNOWN Swiss HIV Cohort Study (SHCS)
Sep 29, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard D MooreJohn G Bartlett

❮ Previous
Next ❯

Citations

Feb 18, 2016·American Journal of Public Health·Kriti M JainUNKNOWN PC Implementation Team
Sep 16, 2015·AIDS and Behavior·Edward R HammondGlenn J Treisman
Aug 24, 2016·Current HIV/AIDS Reports·Damani A PiggottKevin E Yarasheski
Sep 10, 2017·AIDS and Behavior·Joëlla W AdamsBrandon D L Marshall
Jul 19, 2019·AIDS Care·Symone MayMadeline Y Sutton
Oct 28, 2019·Annual Review of Medicine·Myron S CohenMarybeth McCauley
Oct 30, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Linda BeerUNKNOWN Medical Monitoring Project
Jun 9, 2016·Current Opinion in HIV and AIDS·Sophie Abgrall, Julia Del Amo
Apr 20, 2020·AIDS and Behavior·Heidi E HuttonMary E McCaul
Apr 6, 2021·Current HIV/AIDS Reports·Kristine M Erlandson, Damani A Piggott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.